1 Market Overview
1.1 Anti Obesity Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Oral Medicine
1.2.2 Diet Patch
1.2.3 Diet Tea
1.3 Market Analysis by Application
1.3.1 Men
1.3.2 Women
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2028)
1.4.2 Europe Market States and Outlook (2015-2028)
1.4.3 China Market States and Outlook (2015-2028)
1.4.4 Japan Market States and Outlook (2015-2028)
1.4.5 Southeast Asia Market States and Outlook (2015-2028)
1.4.6 India Market States and Outlook (2015-2028)
1.4.7 Brazil Market States and Outlook (2015-2028)
1.4.8 GCC Countries Market States and Outlook (2015-2028)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Anti Obesity Drugs Market Size Analysis from 2015 to 2028
1.6.1 Global Anti Obesity Drugs Market Size Analysis from 2015 to 2028 by Consumption Volume
1.6.2 Global Anti Obesity Drugs Market Size Analysis from 2015 to 2028 by Value
1.6.3 Global Anti Obesity Drugs Price Trends Analysis from 2015 to 2028
2 Global Anti Obesity Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Anti Obesity Drugs (Volume and Value) by Type
2.1.1 Global Anti Obesity Drugs Consumption and Market Share by Type (2015-2020)
2.1.2 Global Anti Obesity Drugs Revenue and Market Share by Type (2015-2020)
2.2 Global Anti Obesity Drugs (Volume and Value) by Application
2.2.1 Global Anti Obesity Drugs Consumption and Market Share by Application (2015-2020)
2.2.2 Global Anti Obesity Drugs Revenue and Market Share by Application (2015-2020)
2.3 Global Anti Obesity Drugs (Volume and Value) by Region
2.3.1 Global Anti Obesity Drugs Consumption and Market Share by Region (2015-2020)
2.3.2 Global Anti Obesity Drugs Revenue and Market Share by Region (2015-2020)
3 United States Anti Obesity Drugs Market Analysis
3.1 United States Anti Obesity Drugs Consumption and Value Analysis
3.2 United States Anti Obesity Drugs Consumption Volume by Type
3.3 United States Anti Obesity Drugs Consumption Structure by Application
4 Europe Anti Obesity Drugs Market Analysis
4.1 Europe Anti Obesity Drugs Consumption and Value Analysis
4.2 Europe Anti Obesity Drugs Consumption Volume by Type
4.3 Europe Anti Obesity Drugs Consumption Structure by Application
4.4 Europe Anti Obesity Drugs Consumption by Top Countries
4.4.1 Germany Anti Obesity Drugs Consumption Volume from 2015 to 2020
4.4.2 UK Anti Obesity Drugs Consumption Volume from 2015 to 2020
4.4.3 France Anti Obesity Drugs Consumption Volume from 2015 to 2020
4.4.4 Italy Anti Obesity Drugs Consumption Volume from 2015 to 2020
4.4.5 Spain Anti Obesity Drugs Consumption Volume from 2015 to 2020
4.4.6 Poland Anti Obesity Drugs Consumption Volume from 2015 to 2020
4.4.7 Russia Anti Obesity Drugs Consumption Volume from 2015 to 2020
5 China Anti Obesity Drugs Market Analysis
5.1 China Anti Obesity Drugs Consumption and Value Analysis
5.2 China Anti Obesity Drugs Consumption Volume by Type
5.3 China Anti Obesity Drugs Consumption Structure by Application
6 Japan Anti Obesity Drugs Market Analysis
6.1 Japan Anti Obesity Drugs Consumption and Value Analysis
6.2 Japan Anti Obesity Drugs Consumption Volume by Type
6.3 Japan Anti Obesity Drugs Consumption Structure by Application
7 Southeast Asia Anti Obesity Drugs Market Analysis
7.1 Southeast Asia Anti Obesity Drugs Consumption and Value Analysis
7.2 Southeast Asia Anti Obesity Drugs Consumption Volume by Type
7.3 Southeast Asia Anti Obesity Drugs Consumption Structure by Application
7.4 Southeast Asia Anti Obesity Drugs Consumption by Top Countries
7.4.1 Indonesia Anti Obesity Drugs Consumption Volume from 2015 to 2020
7.4.2 Thailand Anti Obesity Drugs Consumption Volume from 2015 to 2020
7.4.3 Philippines Anti Obesity Drugs Consumption Volume from 2015 to 2020
7.4.4 Malaysia Anti Obesity Drugs Consumption Volume from 2015 to 2020
7.4.5 Singapore Anti Obesity Drugs Consumption Volume from 2015 to 2020
7.4.6 Vietnam Anti Obesity Drugs Consumption Volume from 2015 to 2020
8 India Anti Obesity Drugs Market Analysis
8.1 India Anti Obesity Drugs Consumption and Value Analysis
8.2 India Anti Obesity Drugs Consumption Volume by Type
8.3 India Anti Obesity Drugs Consumption Structure by Application
9 Brazil Anti Obesity Drugs Market Analysis
9.1 Brazil Anti Obesity Drugs Consumption and Value Analysis
9.2 Brazil Anti Obesity Drugs Consumption Volume by Type
9.3 Brazil Anti Obesity Drugs Consumption Structure by Application
10 GCC Countries Anti Obesity Drugs Market Analysis
10.1 GCC Countries Anti Obesity Drugs Consumption and Value Analysis
10.2 GCC Countries Anti Obesity Drugs Consumption Volume by Type
10.3 GCC Countries Anti Obesity Drugs Consumption Structure by Application
10.4 GCC Countries Anti Obesity Drugs Consumption Volume by Major Countries
10.4.1 Saudi Arabia Anti Obesity Drugs Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates Anti Obesity Drugs Consumption Volume from 2015 to 2020
10.4.3 Qatar Anti Obesity Drugs Consumption Volume from 2015 to 2020
10.4.4 Bahrain Anti Obesity Drugs Consumption Volume from 2015 to 2020
11 Manufacturers Profiles
11.1 Orexigen Therapeutics
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 Orexigen Therapeutics Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.1.4 Orexigen Therapeutics Anti Obesity Drugs Sales by Region
11.2 Arena Pharmaceuticals
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.2.4 Arena Pharmaceuticals Anti Obesity Drugs Sales by Region
11.3 GlaxoSmithKline
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 GlaxoSmithKline Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.3.4 GlaxoSmithKline Anti Obesity Drugs Sales by Region
11.4 Novo Nordisk
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 Novo Nordisk Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.4.4 Novo Nordisk Anti Obesity Drugs Sales by Region
11.5 Boehringer Ingelheim
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.5.4 Boehringer Ingelheim Anti Obesity Drugs Sales by Region
11.6 Merck
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Merck Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.6.4 Merck Anti Obesity Drugs Sales by Region
11.7 Eisai
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Eisai Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.7.4 Eisai Anti Obesity Drugs Sales by Region
11.8 Vivus
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Vivus Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.8.4 Vivus Anti Obesity Drugs Sales by Region
11.9 AstraZeneca
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 AstraZeneca Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.9.4 AstraZeneca Anti Obesity Drugs Sales by Region
11.10 Shionogi
11.10.1 Business Overview
11.10.2 Products Analysis
11.10.3 Shionogi Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.10.4 Shionogi Anti Obesity Drugs Sales by Region
11.11 Rhythm Pharmaceuticals
11.11.1 Business Overview
11.11.2 Products Analysis
11.11.3 Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.11.4 Rhythm Pharmaceuticals Anti Obesity Drugs Sales by Region
11.12 Zafgan
11.12.1 Business Overview
11.12.2 Products Analysis
11.12.3 Zafgan Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.12.4 Zafgan Anti Obesity Drugs Sales by Region
11.13 Norgine
11.13.1 Business Overview
11.13.2 Products Analysis
11.13.3 Norgine Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.13.4 Norgine Anti Obesity Drugs Sales by Region
11.14 Roche
11.14.1 Business Overview
11.14.2 Products Analysis
11.14.3 Roche Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.14.4 Roche Anti Obesity Drugs Sales by Region
11.15 Pfizer
11.15.1 Business Overview
11.15.2 Products Analysis
11.15.3 Pfizer Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.15.4 Pfizer Anti Obesity Drugs Sales by Region
11.16 Alizyme
11.16.1 Business Overview
11.16.2 Products Analysis
11.16.3 Alizyme Anti Obesity Drugs Sales, Price, Revenue, Gross Margin
11.16.4 Alizyme Anti Obesity Drugs Sales by Region
13 Global Anti Obesity Drugs Market Forecast (2020-2028)
13.1 Global Anti Obesity Drugs Consumption Volume, Revenue and Price Forecast (2020-2028)
13.1.1 Global Anti Obesity Drugs Consumption Volume and Growth Rate Forecast (2020-2028)
13.1.2 Global Anti Obesity Drugs Value and Growth Rate Forecast (2020-2028)
13.1.3 Global Anti Obesity Drugs Price and Trend Forecast (2020-2028)
13.2 Global Anti Obesity Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2020-2028)
13.2.1 Global Anti Obesity Drugs Consumption Volume and Growth Rate Forecast by Region (2020-2028)
13.2.2 Global Anti Obesity Drugs Value and Growth Rate Forecast by Region (2020-2028)
13.3 Global Anti Obesity Drugs Consumption Volume, Revenue and Price Forecast by Type (2020-2028)
13.3.1 Global Anti Obesity Drugs Consumption Forecast by Type (2020-2028)
13.3.2 Global Anti Obesity Drugs Revenue Forecast by Type (2020-2028)
13.3.3 Global Anti Obesity Drugs Price Forecast by Type (2020-2028)
13.4 Global Anti Obesity Drugs Consumption Volume Forecast by Application (2020-2028)
14 Research Conclusions
15 Appendix
15.1 Methodology
15.2 Research Data Source
